Cancer Research UK Logo London Research Institute
Research
Svend Petersen-Mahrt
Group Members
Overview
Publications
Research
Core Technology Facilities
Past Group Leaders
Publications Print this page Print this page
Feedback Feedback

back to listSvend Petersen-Mahrt

Selected Publications

Coker HA, Morgan HD and Petersen-Mahrt SK. Genetic and in vitro assays of DNA deamination. In: Campbell JL, Modrich P (ed.), Methods in Enzymology, Vol 408: DNA Repair. London: Academic Press, 2006; 156-170. PubMed

Petersen-Mahrt S. DNA deamination in immunity. Immunol Rev 2005; 203: 80-97. PubMed

Morgan HD, Dean W, Coker HA, Reik W and Petersen-Mahrt SK. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J Biol Chem 2004; 279: 52353-52360. PubMed

Petersen-Mahrt SK and Neuberger MS. In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1). J Biol Chem 2003; 278: 19583-19586. PubMed

Petersen-Mahrt SK, Harris RS and Neuberger MS. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002; 418: 99-103. PubMed


Primary Research Publications

2009

Petersen-Mahrt SK. Estrogen Alters Immune System Defenses. Immunol News 2009; 9 (2):7-8.

Pauklin S, Burkert JS, Martin J, Osman F, Weller S, Boulton SJ, Whitby MC, Petersen-Mahrt SK. Alternative Induction of Meiotic Recombination From Single-Base Lesions of DNA Deaminases. Genetics 2009; 182 (1):41-54.  UKPubMed (open access);  PubMed;  DOI: 10.1534/genetics.109.101683.

Petersen-Mahrt SK, Coker HA, Pauklin S. DNA deaminases: AIDing hormones in immunity and cancer. J Mol Med 2009; 87 (9 Spec Iss):893-897.  UKPubMed (open access);  PubMed;  DOI: 10.1007/s00109-009-0496-6.

Pauklin S, Petersen-Mahrt SK. Progesterone Inhibits Activation-Induced Deaminase by Binding to the Promoter. J Immunol 2009; 183 (2):1238-1244.  PubMed.

Pauklin S, Scrnandez IV, Bachmann G, Ramiro AR, Petersen-Mahrt SK. Estrogen directly activates AID transcription and function. J Exp Med 2009; 206 (1):99-111.  UKPubMed (open access);  PubMed;  DOI: 10.1084/jem.20080521.

2007

Coker HA, Petersen-Mahrt SK. AID's distributive mode of action: A definition. DNA Repair (Amst) 2007; 6 (6):693-694.

Coker HA, Petersen-Mahrt SK. The nuclear DNA deaminase AID functions distributively whereas cytoplasmic APOBEC3G has a processive mode of action. DNA Repair (Amst) 2007; 6 (2):235-243.  DOI: 10.1016/j.dnarep.2006.10.001.

2006

Coker HA, Morgan HD, Petersen-Mahrt SK. Genetic and in vitro assays of DNA deamination. Methods Enzymol 2006; 408 :156-170.

2005

Conticello SG, Thomas CJF, Petersen-Mahrt SK, Neuberger MS. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol Biol Evol 2005; 22 (2):367-377.

Petersen-Mahrt S. DNA deamination in immunity. Immunol Rev 2005; 203 :80-97.

2004

Morgan HD, Dean W, Coker HA, Reik W, Petersen-Mahrt SK. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues - Implications for epigenetic reprogramming. J Biol Chem 2004; 279 (50):52353-52360.

Beale RCL, Petersen-Mahrt SK, Watt IN, Harris RS, Rada C, Neuberger MS. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J Mol Biol 2004; 337 (3):585-596.


Other publications

Petersen-Mahrt SK. Estrogen Alters Immune System Defenses. Immunology in the News 2009; 9(2):7-8.

Petersen-Mahrt SK, Coker HA, Pauklin S. DNA deaminases: AIDing hormones in immunity and cancer. J Mol Med 2009; 87(9): 893-897.

back to list


Access keys   Accessibility   Privacy   Terms & Conditions   Top of page

Cancer Research UK is a registered charity No.1089464.
Registered as a company limited by guarantee in England & Wales No. 4325234.
Registered address 61 Lincoln's Inn Fields, London, WC2A 3PX.